Resource Mapping - Financial Needs
Resource Mapping - Financial Needs
Funding is based on the data provided by Donors which may not be complete
| Technical Areas | NAPHS Costs | Partner NAPHS Investment | Government NAPHS investment | Estimated Overall Partner H.S Investment (Not limited to NAPHS) |
|---|---|---|---|---|
| P.1 National Legislation, Policy and Financing | $0 | $0 | $0 | $0 |
| P.2 IHR Coordination, Communication and Advocacy | $0 | $0 | $0 | $0 |
| P.3 Antimicrobial Resistance | $0 | $0 | $0 | $0 |
| P.4 Zoonotic Disease | $0 | $0 | $0 | $0 |
| P.5 Food Safety | $0 | $0 | $0 | $0 |
| P.6 Biosafety and Biosecurity | $0 | $0 | $0 | $0 |
| P.7 Immunization | $0 | $0 | $0 | $0 |
| D.1 National Laboratory System | $0 | $0 | $0 | $0 |
| D.2 Real-Time Surveillance | $0 | $0 | $0 | $0 |
| D.3 Reporting | $0 | $0 | $0 | $0 |
| D.4 Workforce Development | $0 | $0 | $0 | $0 |
| R.1 Preparedness | $0 | $0 | $0 | $0 |
| R.2 Emergency Response Operations | $0 | $0 | $0 | $0 |
| R.3 Linking Public Health and Security Authorities | $0 | $0 | $0 | $0 |
| R.4 Medical Countermeasures | $0 | $0 | $0 | $0 |
| R.5 Risk Communication | $0 | $0 | $0 | $0 |
| PoE. Points of Entry (PoEs) | $0 | $0 | $0 | $0 |
| CE. Chemical Events | $0 | $0 | $0 | $0 |
| RE. Radiation Emergencies | $0 | $0 | $0 | $0 |
$ 0
Total NAPHS Costs$ 0
Pledged Partners Contribution to NAPHS$ 0
Pledged Government Contribution to NAPHS$ 0
Partners and Government Contribution To Overall Health Security and NAPHS$ 0
Government Contribution to Overall HS & NAPHSLAO - Conducted
To test the national pandemic preparedness and response plan
NIAID Workshop on Pandemic Preparedness: The Prototype Pathogen Approach
Date
2021-11-08 - 2021-11-09
Region
Brief description
NIAID will host a workshop November 8-9: Pandemic Preparedness: The Prototype Pathogen Approach to Accelerate Medical Countermeasures - Vaccines and Monoclonal Antibodies.
The objective of this workshop is to introduce NIAID’s pandemic preparedness strategy and request feedback from the scientific community on prioritizing prototype pathogens within viral families of highest pandemic potential for medical countermeasure development. For each of 7 viral families, experts will summarize current knowledge of the basic and translational research landscape, describe research and intervention gaps, and propose suitable prototype pathogens for further study and medical countermeasure development.
Registration information and the current agenda are available here.